VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
50 hedge funds and large institutions have $48.8M invested in Viracta Therapeutics, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
27% less capital invested
Capital invested by funds: $67.2M → $48.8M (-$18.4M)
Holders
50
Holding in Top 10
1
Calls
$689K
Puts
$155K
Top Buyers
| 1 | +$2.18M | |
| 2 | +$441K | |
| 3 | +$417K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$367K |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$272K |
Top Sellers
| 1 | -$1.7M | |
| 2 | -$1.11M | |
| 3 | -$975K | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$829K |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$503K |